The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to ALG-801, Alivegen ’s experimental ...
Chronic pain can be particularly difficult to manage during the holidays, says columnist Jen Cueva, who shares how PH disrupted her plans.
Cereno's expanded access program for investigational therapy CS1 covers 10 PAH patients, following a Phase 2a clinical trial.
As columnist Colleen Steele sets her intentions for 2025, she promises the PH community that she will continue raising awareness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback